Chinese Journal of Stroke ›› 2020, Vol. 15 ›› Issue (02): 167-168.DOI: 10.3969/j.issn.1673-5765.2020.02.011
Previous Articles Next Articles
Online:
Published:
杨中华
通讯作者:
YANG Zhong-Hua. Lancet N: A Breakthrough on Long-term Dual Antiplatelet Therapy for Stroke Secondary Prevention[J]. Chinese Journal of Stroke, 2020, 15(02): 167-168.
杨中华. Lancet N：卒中二级预防长期双联抗血小板的突破[J]. 中国卒中杂志, 2020, 15(02): 167-168.
0 / / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinastroke.org.cn/EN/10.3969/j.issn.1673-5765.2020.02.011
https://www.chinastroke.org.cn/EN/Y2020/V15/I02/167
TOYODA K，UCHIYAMA S，YAMAGUCHI T，et al. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan：a multicentre，open-label，randomised controlled trial[J]. Lancet Neurol，2019，18（6）：539-548.
